<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="80759">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02107547</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 13-0085</org_study_id>
    <nct_id>NCT02107547</nct_id>
  </id_info>
  <brief_title>Study Evaluating Outcomes After Biceps Tenodesis or Labral Repair for the Treatment of Type 2 Superior Glenoid Labrum Lesions</brief_title>
  <official_title>Evaluation of Biceps Tenodesis vs Labral Repair for Type 2 SLAP Lesions, A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Chicago</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Chicago</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine which of the two alternative surgical interventions
      (biceps tenodesis or labrum repair surgery) is better in the treatment of Type 2 SLAP
      lesions.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2014</start_date>
  <primary_completion_date type="Anticipated">June 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>American Shoulder and Elbow Surgeons (ASES) Shoulder Score</measure>
    <time_frame>one year</time_frame>
    <safety_issue>No</safety_issue>
    <description>The scale measures pain from 0 to 10 and also includes a questionnaire for assessing the activity of daily living.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>EuroQol EQ-5D</measure>
    <time_frame>one year</time_frame>
    <safety_issue>No</safety_issue>
    <description>The questionnaire measures mobility, ability to care for self, ability to perform usual activities, pain/discomfort, and anxiety/depression</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Type 2 SLAP Lesions</condition>
  <arm_group>
    <arm_group_label>Biceps tenodesis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>32 subjects in the study will receive biceps tenodesis as a surgical intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Labral repair</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>32 subjects in the study will receive labral repair as a surgical intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Biceps tenodesis</intervention_name>
    <arm_group_label>Biceps tenodesis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Labral repair</intervention_name>
    <arm_group_label>Labral repair</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with MRI diagnosed SLAP 2 lesion

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lewis L Shi, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Chicago</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lewis L Shi, MD</last_name>
    <phone>773-795-3583</phone>
    <email>lshi@bsd.uchicago.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>The University of Chicago Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Lewis L Shi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>May 29, 2014</lastchanged_date>
  <firstreceived_date>April 4, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Randomized Controlled Trial (RCT)</keyword>
  <keyword>Type 2 SLAP lesions</keyword>
  <keyword>labral tear</keyword>
  <keyword>biceps tenodesis</keyword>
  <keyword>shoulder surgery</keyword>
  <keyword>RCT</keyword>
  <keyword>Comparison between two alternative surgical procedures</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
